Open

CCTG- MA-39_Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive and T3N0 Breast Cancer

The purpose of this study is to compare any good and bad effects of not giving regional radiotherapy to using regional radiotherapy. This study will help researchers learn if not giving regional radiotherapy is just as good as using regional radiotherapy. To be better, the approach of not giving regional radiotherapy should keep breast cancer from coming back as good as giving regional radiotherapy.

Age & Gender

35 years ~ 99 years
Female

Visit Availability

Standard business hours (M-F, 8-5)
Visits can be combined with regular clinical appointments

Location

United States (Nationwide)

What will be asked of you

The study involves study radiation therapy, blood draws, urine test, and tissue sample

Total length of participation:
6-24 months

Looking for Specific Volunteers

Able to participate:

Women 36 years of age or older with newly diagnosed invasive carcinoma of the breast that has not spread to other areas of the body
Must have been previously treated with Breast Conserving Surgery (BCS) or mastectomy
Must have had endocrine (hormone) therapy started or planned

Not eligible if:

Patients who have another current or prior diagnosis besides prostate cancer in the past 5 years
Patients who are pregnant

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Lineberger Comprehensive Cancer Center
NC Cancer Hospital (Basnight)
UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Dana Casey
Radiation Oncology - Chapel Hill

Study Type

Clinical or Medical
Observational

Study Topics

Cancer (Breast)
Women's Health
Men's Health

IRB Number

22-2777

ClinicalTrials.gov

NCT03488693

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.